The Role of Topical Therapies Involving Androgen Hormones in Acne and Androgenetic Alopecia

The presentation focuses on the use of topical therapies involving androgen hormones for conditions like androgenetic alopecia and acne. The speaker reviews the historical context of approved treatments, specifically the effectiveness of finasteride in hair loss treatment, where studies show that a majority of men maintain or gain hair over time. However, concerns about side effects from finasteride have led to increased interest in topical formulations that may reduce systemic exposure and associated risks. Promising results from a 0.25% topical finasteride solution show similar efficacy to oral finasteride with significantly fewer side effects, prompting further exploration into additional topical androgen modulators. New agents such as class Coderone and pyrolutamide, which block androgen receptors and offer localized effects without systemic side effects, are being investigated, although more research is needed to confirm their efficacy. Overall, while there are advancements in topical androgen therapies, the need for extensive studies and FDA approvals remains crucial for clinical application. The speaker also highlights an upcoming World Congress for Hair Research aimed at advancing knowledge in this field.